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Background: Little is known about the temporal evolution of pain severity in persons with knee osteo-
arthritis (OA). We sought to describe the pain trajectory over 6 years in a cohort of subjects with
radiographic, symptomatic knee OA.
Methods: We used data from the Osteoarthritis Initiative (OAI), a multi-center, longitudinal study of
subjects with diagnosed radiographic evidence of knee OA. Pain was assessed at baseline and annually
for 6 years. Our analysis cohort included subjects with symptomatic knee OA at baseline, deﬁned as
baseline KellgreneLawrence (KL) score 2 with Western Ontario and McMaster Universities Osteoar-
thritis Index (WOMAC) pain score >0. We used group-based trajectory modeling to identify distinct
patterns of pain progression over a 6-year follow-up. Factors examined included sex, race, education,
comorbidities, age, body mass index (BMI), alignment, KL grade, and depression.
Results: We used data from 1753 OAI participants with symptomatic knee OA. Mean baseline WOMAC
pain score was 26.5 (0e100, 100¼worst) with standard deviation (SD) 19. Group-based trajectory
modeling identiﬁed ﬁve distinct pain trajectories; baseline pain scores for each ranged from 15 to 62.
None of the trajectories exhibited substantial worsening. One ﬁfth of subjects in the two trajectories with
the greatest pain underwent total knee replacement (TKR) over follow-up. Higher KL grade, obesity,
depression, medical comorbidities, female sex, non-white race, lower education, and younger age were
associated with trajectories characterized by greater pain.
Conclusion: We found that knee pain changes little, on average, over 6 years in most subjects. These
observations suggest knee OA is characterized by persistent rather than inexorably worsening symptoms.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Symptomatic knee osteoarthritis (OA) has become a growing
burden for patients and the broader American healthcare system,
occurring in an estimated 6% of adults 30 years of age or older1 and
in 13% of people age 60 and over2. Persons with OA of the lower
extremities have lower quality of life compared to persons without
OA3 and utilize more healthcare resources4,5. Knee pain is the pri-
mary reason that people with knee OA seek medical care6.J.E. Collins, Orthopedics and
of Orthopedic Surgery, Brig-
16, Boston, MA 02115, USA.
ollins).
ternational. Published by Elsevier LPathologically, the disease is characterized by progressive hya-
line articular cartilagedamage coupledwith changes in subchondral
bone and other joint structures. In the course of these structural
changes in the joint, affected persons may experience both symp-
tomatic joint pain as well as functional disability1. Beyond replacing
the joint surgically through arthroplasty, there are no treatments
available to reverse the course of structural progression.
While associations between structural change, symptoms, and
functional impairment are not well understood, both structural
deterioration and symptoms are thought to gradually and consis-
tently worsen over time7,8. Recent work challenges this traditional
understanding. Felson et al. evaluated structural changes in knee
OA over time by studying radiographic images from the Osteoar-
thritis Initiative (OAI). The study suggested that structuraltd. All rights reserved.
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gressing are likely to experience further worsening whereas knees
that have been stable are likely to remain stable9. Peters et al. and
Dieppe et al. each conducted longitudinal studies evaluating co-
horts with knee OA over 7- and 8-years, respectively. While both
study cohorts demonstrated overall declines in pain and function
over time, the outcomes of individual subjects within these cohorts
were heterogeneous with some subjects experiencing worsening
and others improvement10,11.
These studies of symptomatic and structural progression sug-
gest that persons with knee OA may have diverse disease trajec-
tories over time; however, traditional approaches to longitudinal
data analysis may not be suitable in the presence of heterogeneity
leading to distinct outcome trajectories12. More work is needed to
identify distinct trajectories in the natural history of pain for per-
sons with knee OA; indeed, better understanding of these trajec-
tories in persons affected by knee OA would offer important
insights into clinical prognosis and would help inform treatment
plans. This study seeks to describe the trajectory of OA-related pain
over the course of 6 years by examining a large cohort of subjects
with radiographic, symptomatic knee OA. A group-based trajec-
tories approach has been designed to highlight the distinct pattern
of outcomes.
Methods
Sample
We selected data from the OAI, a multi-center, longitudinal
observational study of knee OA. Men and women ages 45e79 were
enrolled at four centers between 2004 and 2006. Subjects were
assessed annually; as of October 2013, clinical data were available
through the 72 months visit. The data and additional study details
are publicly available at http://oai.epi-ucsf.org. We selected all
knees with radiographic knee OA at baseline, deﬁned by Kellgrene
Lawrence (KL) score of two or higher based on the central reading
of a standardized ﬁxed-ﬂexion radiograph13. For subjects with
radiographic OA in both knees, we selected the knee with the worst
pain at baseline to create a database with one observation per
subject. For subjects with radiographic OA in both knees and equal
pain in each knee, we randomly selected a knee. We censored
subjects that underwent primary total knee replacement (TKR)
over the course of the study at the time of TKR; data was included
up to and including the visit prior to TKR.
Primary outcome
Our primary outcome was the pain subscale from the Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC)14. The WOMAC pain scale contains ﬁve items rated on a
Likert scale from 0 (no pain) to 4 (extreme pain). The items are
summed to create a total score that was rescaled to 0e100, where
higher scores indicate more severe pain. In describing baseline
pain, thresholds of 15 and 40 were used to deﬁne categories of pain
severity. Scores 15 were deﬁned as mild pain, 15e40 as mild to
moderate pain, and above 40 as moderate to severe pain. The lower
threshold was selected to reﬂect the point at which subjects
experience clinically relevant OA-related pain15,16. Our mid-point
deﬁnition was based on literature describing pain scores of
roughly 40e50 points as categorically moderate17,18.
Factors associated with pain
We examined the impact of baseline age, sex, body mass index
(BMI), comorbidities, KL grade, alignment, education, race,depression, andmedication use on pain trajectories. Alignment was
measured on full limb radiographs using a goniometer19. Comor-
bidities were summarized with the Charlson Comorbidity index20.
Depression was deﬁned as a Center for Epidemiologic Studies
Depression Scale (CES-D) score >1621. In multivariable models, BMI
was classiﬁed as obese (>30 kg/m2) vs non-obese, race as white vs
non-white, education as college vs no college, and comorbidities as
any vs none. Frequent medication use was deﬁned as use of
medication for knee pain more than half the days of the month in
the past 12 months.
Statistical methods
We used group-based trajectory modeling to identify groups of
individuals following similar patterns of pain progression12. This
method uses a multinomial modeling strategy to identify multiple
trajectories, allowing for the detection of distinct outcome groups.
Unlike growth curve modeling, which allows for individual vari-
ability around a mean population trend, group-based trajectory
modeling allows for the possibility that there are distinct sub-
groups within a population12. We used a censored normal model,
which allows for clustering at the minimum and maximum and is
useful for scales with a pre-speciﬁed range such as theWOMAC.We
iteratively considered between three and six trajectories and
allowed for up to a fourth-order polynomial in each trajectory. We
used the Bayesian information criterion (BIC) to aid in selecting the
optimal model. The BIC is a measure of model ﬁt that balances
improvements in model likelihood with the number of parameters
estimated. Higher BIC values indicate bettermodel ﬁt; however, the
BIC does not always clearly identify the optimal number of groups
in group-based trajectory modeling12. Therefore, we also took into
account group size and stability. We sought models with at least 50
participants in each group (approximately 3% of the sample) and
models in which size and shape of each trajectory did not change
substantially as we adjusted the order of polynomial.
We used posterior group-membership probabilities to assess
model ﬁt. For a speciﬁc individual, the posterior group-
membership probability measures the likelihood of belonging to
each trajectory group. For example, in a model with three trajec-
tories, each individual has three posterior group membership
probabilities that sum to 1 indicating the likelihood of belonging to
each trajectory. Individuals are then assigned to the trajectory with
the maximum posterior group-membership probability. Ideally,
this probability is close to 1, suggesting only a small chance that the
individual could belong to a different trajectory than the one
assigned. Nagin suggests that the average posterior probability in
each trajectory should be at least 0.712. We assessed heterogeneity
within each trajectory by calculating the proportion of subjects
demonstrating sustained worsening or improvement, which we
deﬁned as a change greater than the minimal clinically important
difference (MCID) sustained at subsequent visits. The MCID was
estimated on the WOMAC scale by Angst and colleagues as 11
points for worsening and 7.5 points for improvement15.
We used a three-stage approach to investigate the association
between baseline covariates and the likelihood of membership in a
speciﬁc trajectory. First, we selected the optimal model as
described above. Then we used a multivariable multinomial logit
model to examine the association between trajectory group
assignment and covariates. In this step, we identiﬁed statistically
signiﬁcant predictors of trajectory group assignment. Finally, we re-
estimated the trajectories by including the covariates statistically
signiﬁcantly associated with a higher likelihood of a speciﬁc pain
trajectory in stage two, jointly estimating the trajectories and as-
sociations between the trajectories and covariates. This association
between covariates and trajectory group membership was
Table I
Baseline characteristics
Age, mean (SD) 62.2 (8.9)
n (%) female 1039 (59.3%)
BMI (mean (SD)) 30.1 (4.9)
Comorbidities
0 1257 (72.5%)
1 280 (16.1%)
2þ 197 (11.4%)
Race
White or Caucasian 1290 (73.6%)
Black or African American 413 (23.6%)
Asian 17 (1.0%)
Other Non-white 33 (1.9%)
Education
<High school 80 (4.6%)
High school graduate 717 (41.2%)
College graduate 464 (26.6%)
Graduate degree 481 (27.6%)
Depression (CES-D Score 16) 205 (11.8%)
Kellgren and Lawrence
2 917 (52.3%)
3 596 (34.0%)
4 240 (13.7%)
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allowed for the evaluation of one covariate’s inﬂuence on the
probability of belonging to one trajectory over another comparative
trajectory. This three-stage approach is necessary because the
classiﬁcation into each trajectory is based on the posterior group-
membership probability. Uncertainty around these classiﬁcations
must be taken into account when examining the association be-
tween group membership and covariates.
To investigate the association between pain and TKR, we plotted
mean WOMAC pain by visit and TKR status. Following the meth-
odology of Dodge et al., we created an indicator variable for
whether or not each subject underwent TKR over the course of
follow-up and a variable indicating at which visit the TKR was re-
ported. We included the TKR information as a covariate and re-
estimated the trajectories two ways: one model included the in-
dicator for any TKR and one model included timing of the TKR
visit22.
All analyses were conducted using statistical analysis system
(SAS) 9.3 (SAS Institute, Cary NC).We used SAS PROC TRAJ, a custom
SAS procedure available for free download23,24.Alignment
No malignment 457 (26.2%)
Varus 497 (28.5%)
Valgus 792 (45.4%)
WOMAC pain score (scaled 0e100) (mean (SD)) 26.5 (18.9)
12M: WOMAC pain group
Mild (15) 712 (40.6%)
Moderate (40) 696 (39.7%)
Severe (40þ) 345 (19.7%)
WOMAC function score (scaled 0e100) (mean (SD)) 23.4 (18.5)
Number for whom either knee limited activities
due to pain, aching or stiffness, past 30 days
708 (40.5%)
Dropout
No dropout 1448 (82.6%)
After 60M 58 (3.3%)Secondary analysis
To assess more homogeneous disease groups, we evaluated pain
trajectories separately for each baseline KL grade. We also analyzed
trajectories for the WOMAC function scale. The WOMAC function
scale contains 17 items rated on a Likert scale from 0 (no difﬁculty
with item) to 4 (extreme difﬁculty), which were summed and
rescaled to 0e100. Higher scores indicate greater functional
impairment. Finally, we analyzed pain trajectories for all subjects
with radiographic OA at baseline, including subjects with and
without baseline pain.After 48M 114 (6.5%)
After 36M 37 (2.1%)
After 24M 48 (2.7%)
After 12M 48 (2.7%)
TKR 191 (10.9%)
Prior to 12 months 15
Between 12 and 24 months 27
Between 24 and 36 months 40
Between 36 and 48 months 35
Between 48 and 60 months 38
Between 60 and 72 months 36
Medications
Any medication for pain, aching, or stiffness in the
past 12 months
1282 (73.1%)
Any medication for pain, aching, or stiffness more
than half the days of a month in the past 12 months
709 (40.4%)
Any NSAID/Acetaminophen* 793 (45.3%)
Nonprescription NSAIDS* 452 (25.8%)
Prescription NSAIDS* 145 (8.3%)
Tylenol* 227 (13.0%)
COXIBS* 172 (9.8%)
Strong prescription pain medications (e.g., narcotics)* 51 (2.9%)
Doxycycline* 5 (0.3%)
Any supplementy 696 (39.7%)
Chondroitin sulfatey 621 (35.6%)
Glucosaminey 691 (39.5%)
Injectionsy 92 (5.3%)
* Use during more than half the days in the past 30 days.
y Use within the past 6 months.Results
Sample
Our ﬁnal sample was 1753 subjects/knees with KL 2 and
WOMAC pain >0 at baseline. The sample was 59% female with an
average age of 62 (standard deviation (SD) 9). Forty-nine percent of
the sample was obese with an average BMI of 30 (SD 5). Fifty-two
percent had KL 2 radiographic severity, 34% KL 3, and 14% KL 4.
The average WOMAC pain at baseline was 27 (SD 19). Forty-one
percent of subjects had a WOMAC pain score 15, 40% were be-
tween 15 and 40, and 20% had a score greater than 40. The sample
also reported functional impairment with an average WOMAC
function score of 23 (SD 19) (Table I). One hundred ninety-one
subjects (11%) underwent primary TKR on the selected knee dur-
ing the 72 months of follow-up. Among those who had TKR, 8% had
surgery prior to the 12-month visit, 14% between 12 and 24months,
21% between 24 and 36 months, 18% between 36 and 48 months,
20% between 48 and 60 months, and 19% between 60 and 72
months.
At baseline, 73% of the sample reported using medication for
pain, aching or stiffness in the past 12 months, with 40% reporting
using medication more than half the days of the month for the past
12 months. The most commonly used medications were nonpre-
scription non-steroidal anti-inﬂammatory drugs (NSAIDS) (26%),
Tylenol (13%), and prescription NSAIDS (8%). Glucosamine (39%)
and chondroitin sulfate (36%) were also popular treatments.
Eleven percent of subjects reported frequent medication use
(using medications for knee pain, aching, or stiffness for more than
half the days over the past 12 months) over the course of all follow-
up visits, while 51% reported frequent medication use at somefollow-up visits and not others. The remaining 38% did not report
frequent medication use at any follow-up visit.
Group-based trajectory modeling
Our analysis identiﬁed ﬁve distinct pain trajectories: no pain,
mild pain, lowmoderate pain, high moderate pain, and severe pain
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ranged from 0.80 for low moderate pain to 0.87 for severe pain,
indicative of good model ﬁt. None of the trajectories showed sub-
stantial worsening or improvement over time. Participants with
moderate pain tended to stay in moderate pain while participants
with more severe pain tended to stay in severe pain.
All of the trajectories suggested some improvement between
baseline and month 12. For all subjects, the average improvement
from baseline to month 12 was 6 points, while the subsequent
yearly mean change between follow-up visits ranged from 0 points
to a worsening of 2 points. This trend was not a simple matter of
attrition; we saw similar ﬁndings when including only those sub-
jects that did not dropout. As a sensitivity analysis, we restricted
the analysis to visits occurring in months 12 through 72 (omitting
baseline) and re-ﬁt the trajectories. Group-based trajectory
modeling again identiﬁed ﬁve distinct pain trajectories with results
similar to the model including baseline data: none of the trajec-
tories showing substantial worsening or improvement over the
12e72-month follow-up period (Supplementary Fig. 1). The initial
improvement seen after baseline was no longer observed whenwe
restricted the analysis to months 12e72.
We observed some heterogeneity within each trajectory.
Because of the observed trend of improvement after baseline, we
evaluated sustained improvement and worsening from the month
12 visit. Overall, 85% of subjects experienced neither sustained
worsening nor improvement. Analyses within trajectories showed
that 94% of subjects in the no pain trajectory experienced neither
worsening nor improvement, as compared with 88% of subjects in
the mild pain trajectory, 80% of subjects in the low moderate pain
trajectory, 80% of subjects in the high moderate pain trajectory, and
88% of subjects in the severe pain trajectory.
Impact of subject characteristics
In unadjusted analysis, higher KL grade, obesity, depression,
comorbidities, female sex, non-white race, lower education, and
younger age were associated with being in a trajectory character-
ized by greater pain (Table II). With the exception of alignment, all
baseline factors were signiﬁcantly associated with trajectory in the
multivariable model. These statistically signiﬁcant associations
between covariate and trajectory group remained when we
examined bivariate associations between each covariate and tra-
jectory group, rather than examining the associations in a multi-
variable fashion.Fig. 1. Group-based trajectories. WOMAC pain is along the Y-axis and follow-up month
is along the X-axis. Each line represents one distinct trajectory. The labels next to each
trajectory indicate the percent of the population in that trajectory. The ﬁrst trajectory
contains 11% of the cohort, the second trajectory contains 34% of the cohort, the third
trajectory contains 32% of the cohort, the fourth trajectory contains 17% of the cohort,
and the ﬁfth trajectory contains 6% of the cohort.Incorporating the covariates into the estimation of the trajec-
tories had minimal impact on the shape of the trajectories. Results
of multivariable multinomial regression analysis showed that
compared with subjects in the reference trajectory of no pain,
subjects in severe pain were more likely to have a higher KL grade,
be obese, be younger, be female, have depression, be less educated,
have medical comorbidities, and be non-white (Table III,
Supplementary Fig. 2). Compared with subjects in no pain, subjects
in high moderate pain were more likely to have a higher KL grade,
be younger, be female, have depression, be less educated, and have
comorbidities. Compared with subjects in no pain, subjects in low
moderate pain were more likely to have a higher KL grade, be fe-
male, and have depression. We did not identify any covariates un-
der consideration that were signiﬁcantly associated with belonging
in mild pain vs no pain.
TKR
Participants with early TKRs tended to start with higher
WOMAC pain scores at baseline, and on average participants with
TKRs tended to experience a worsening in pain in the visits leading
up to their surgeries (Fig. 2). Undergoing TKR was signiﬁcantly
associated with being in a higher trajectory; including information
about TKR in trajectory estimation did not change the size or shape
of any trajectory.
Secondary analysis
Analyzing the data by baseline KL did not reveal additional
trajectories; the shape of the trajectories was largely the same
across KL groups. Participants with higher KL tended to have more
pain.We identiﬁed only four trajectories for the baseline KL 4 group
and did not identify a “no pain” trajectory (Fig. 3). Fourteen percent
of participants with KL 2 at baseline and 23% of participants with KL
3 at baseline progressed to a higher KL by year 4; these trends in
progression were not met with corresponding increases in pain for
either baseline KL group.
The results of the WOMAC function analysis were similar to the
WOMAC pain analysis. Six distinct trajectories were identiﬁed, with
none of the trajectories showing substantial worsening or
improvement over time.
Including the 381 subjects with baseline radiographic OA but
without baseline pain did not change the number or shape of the
trajectories (Supplementary Fig. 3). However, the proportion of
subjects in the lower pain trajectories increased. Mean baseline
WOMAC pain for the “no pain” group decreased from 15 to 4. Of the
381 subjects, 61% were in the “no pain” trajectory, 34% “mild pain”
trajectory, and 4% “low moderate” trajectory.
Discussion
We used group-based trajectory modeling to identify distinct
longitudinal pain trajectories in a cohort of persons with radio-
graphic knee OA.We identiﬁed ﬁve distinct trajectories, but none of
these demonstrated persistent worsening or improvement over
time, with the exception of improvement after a baseline ﬂare.
Trajectories were deﬁned with respect to pain measured at base-
line. Age, sex, BMI, comorbidities, KL grade, education, race, and
depression were all associated with greater pain. Secondary ana-
lyses investigating pain trajectories by baseline KL and function did
not identify trajectories with persistent worsening or improvement
over time.
Most previous work in this area has focused on pain at the
cohort level. On average, subjects experience modest worsening
over time, although individual results are varied; some subjects
Table II
Baseline characteristics by trajectory (unadjusted)
None (n ¼ 187) Mild (n ¼ 606) Low moderate
(n ¼ 563)
High moderate
(n ¼ 292)
Severe
(n ¼ 105)
Age (mean (SD)) 63.7 (8.5) 62.1 (8.9) 62.7 (8.8) 61.5 (9.0) 59.0 (8.7)
Number female (%) 98 (52%) 347 (57%) 334 (59%) 183 (63%) 77 (73%)
Mean BMI (SD) 29.2 (4.3) 29.3 (4.7) 30.1 (4.7) 31.1 (4.8) 33.5 (5.7)
Number obese (%) 79 (42%) 254 (42%) 279 (50%) 164 (56%) 76 (72%)
Comorbidities
0 145 (78%) 468 (78%) 406 (73%) 183 (63%) 55 (55%)
1 22 (12%) 76 (13%) 96 (17%) 63 (22%) 23 (23%)
2þ 19 (10%) 55 (9%) 57 (10%) 44 (15%) 22 (22%)
Race
White or Caucasian 144 (77%) 490 (81%) 432 (77%) 185 (63%) 39 (37%)
Black or African American 38 (20%) 102 (17%) 115 (20%) 94 (32%) 64 (61%)
Asian 1 (1%) 7 (1%) 6 (1%) 3 (1%) 0 (0%)
Other Non-white 4 (2%) 7 (1%) 10 (2%) 10 (3%) 2 (2%)
Education
<High school 7 (4%) 17 (3%) 21 (4%) 18 (6%) 17 (17%)
High school graduate 61 (33%) 215 (36%) 228 (41%) 147 (51%) 66 (64%)
College graduate 60 (32%) 156 (26%) 167 (30%) 69 (24%) 12 (12%)
Graduate degree 59 (32%) 214 (36%) 144 (26%) 56 (19%) 8 (8%)
Depression (CES-D Score 16) 6 (3%) 43 (7%) 64 (11%) 55 (19%) 37 (37%)
Kellgren and Lawrence
2 127 (68%) 385 (64%) 242 (43%) 121 (41%) 42 (40%)
3 54 (29%) 171 (28%) 214 (38%) 120 (41%) 37 (35%)
4 6 (3%) 50 (8%) 107 (19%) 51 (17%) 26 (25%)
Alignment
Neither 49 (26%) 142 (23%) 157 (28%) 78 (27%) 31 (30%)
Varus 60 (32%) 175 (29%) 152 (27%) 80 (28%) 30 (29%)
Valgus 78 (42%) 288 (48%) 252 (45%) 131 (45%) 43 (41%)
Number for whom either knee limited
activities due to pain, aching or stiffness,
past 30 days
39 (21%) 201 (33%) 224 (40%) 163 (56%) 81 (78%)
Dropout
No dropout 157 (84%) 509 (84%) 467 (83%) 232 (79%) 83 (79%)
After 60M 7 (4%) 24 (4%) 18 (3%) 7 (2%) 2 (2%)
After 48M 10 (5%) 37 (6%) 37 (7%) 25 (9%) 5 (5%)
After 36M 4 (2%) 8 (1%) 14 (2%) 6 (2%) 5 (5%)
After 24M 9 (5%) 11 (2%) 13 (2%) 10 (3%) 5 (5%)
After 12M 0 (0%) 17 (3%) 14 (2%) 12 (4%) 5 (5%)
TKR 1 (1%) 29 (5%) 78 (14%) 62 (21%) 21 (20%)
Prior to 12 months 0 5 4 4 2
Prior to 24 months 0 2 9 9 7
Prior to 36 months 0 6 18 12 4
Prior to 48 months 0 3 16 13 3
Prior to 60 months 1 7 14 13 3
Prior to 72 months 0 6 17 11 2
Medications*
Always 3 (2%) 19 (3%) 74 (14%) 50 (18%) 37 (38%)
Intermittent 55 (29%) 263 (45%) 301 (55%) 187 (67%) 54 (55%)
None 129 (69%) 302 (52%) 171 (31%) 43 (15%) 7 (7%)
* Any medication for pain, aching, or stiffness more than half the days of a month, past 12 months, over course of follow-up.
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severe worsening10,11. One study suggested a pain/mental health
cycle, where pain leads to depression and fatigue which in turn
leads to worsening of pain and function25. Other studies have
suggested links between radiographic characteristics and disease
progression, with the presence of bone marrow lesions, synovitis,
and inﬂammation increasing the risk of symptomatic
progression26,27.
Two previous studies have used a group-based modeling
approach to identify outcome trajectories in OA. Leffondré et al.
identiﬁed four patterns in a cohort of 835 subjects with knee and
hip OA over 5 years of follow-up: (1) regularly increasing (18% of
cohort), (2) regularly decreasing (24%), (3) stable (40%), and (4)
unstable with ﬂuctuations (18%)28. Verkleij et al. examined a cohort
of 222 subjects with hip OA with follow-up every 3 months over a
2-year period. Five distinct trajectories were identiﬁed: (1) stable
mild pain (31%), (2) stable moderate to severe pain (14%), (3) stable
severe pain (14%), (4) mild to moderate progressive pain (22%), and
(5) mild to severe progressive pain (19%)29. While these studiesshowed that some subjects remained stable over time and others
ﬂuctuated or progressed, our study was unable to identify any
trajectories characterized by increasing or decreasing pain over the
course of follow-up. Our study evaluated only persons with knee
OA, while Leffondré et al. included both knees and hips and Verkleij
et al. included only hips. In addition, both studies included subjects
with more severe baseline symptoms; the Leffondré et al. cohort
had an average WOMAC total score of 39 out of 100 at baseline,
while the Verkleij et al. cohort reported an average baseline
WOMAC pain of 34% and 9% underwent hip replacement over 2
years of follow-up. In our OAI cohort, average baseline WOMAC
total and pain scores were 26 and 27, respectively. Only 2.4% of the
cohort underwent TKR by the 2-year visit.
These results have important implications for the way we un-
derstand OA as a disease of structural progression and potentially
non-progressive symptoms. While pain ﬂuctuated over time, our
observation that subject pain did not tend to change over 6 years of
follow-up is more consistent with the characterization of OA as a
disease of chronic rather than progressive symptoms. Because one
Table III
Multivariable regression analysis. Odds ratio (95% CI) for belonging in each trajectory relative to reference trajectory (trajectory 1)
Mild (n ¼ 606) Low moderate (n ¼ 563) High moderate (n ¼ 292) Severe (n ¼ 105)
KL
2 Ref Ref Ref Ref
3 1.0 (0.6e1.6) 2.6 (1.7e4.1) 2.6 (1.6e4.3) 4.3 (2.1e8.6)
4 3.6 (0.9e15.0) 21.9 (6.1e79.1) 25.5 (6.8e95.8) 80.6 (18.7e346.8)
Obesity
Non-obese Ref Ref Ref Ref
Obese 0.9 (0.6e1.4) 1.3 (0.9e1.9) 1.5 (0.9e2.3) 2.3 (1.2e4.4)
Age 0.98 (0.96e1.00) 0.98 (0.96e1.00) 0.97 (0.95e1.00) 0.92 (0.89e0.96)
Sex
Male Ref Ref Ref Ref
Female 1.3 (0.8e2.0) 1.6 (1.0e2.3) 2.0 (1.3e3.2) 3.0 (1.5e6.2)
Depression
CES-D <16 Ref Ref Ref Ref
CES-D 16 1.1 (0.3e3.8) 3.1 (1.2e7.9) 3.9 (1.5e10.5) 8.8 (3.1e25.2)
Education
College education Ref Ref Ref Ref
Less than college 0.9 (0.6e1.4) 1.2 (0.8e1.8) 1.7 (1.1e2.6) 5.1 (2.3e11.2)
Comorbidities
Zero Ref Ref Ref Ref
1þ 1.0 (0.6e1.7) 1.3 (0.8e2.2) 2.1 (1.3e3.5) 2.0 (1.0e3.9)
Race
White Ref Ref Ref Ref
Non-white 0.6 (0.4e1.1) 0.9 (0.6e1.5) 1.5 (0.9e2.6) 3.3 (1.7e6.6)
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our observations of nonparallel radiographic and symptomatic
progression have important implications for howwe conceptualize
the relationship between OA structure and symptomatology.
Indeed, while our secondary analysis examined trajectories sepa-
rately for each KL group, we did not identify any trajectories with
persistent worsening, despite the fact that 14% of participants with
KL 2 at baseline and 23% of subjects with KL 3 at baseline pro-
gressed to a higher KL grade within 4 years.Fig. 2. Mean WOMAC pain by TKR status and visit. Mean WOMAC pain is along the Y-
axis and follow-up month is along the X-axis. Subjects are split into seven groups
based on when TKR was reported and each line represents one of these groups. The
lines show mean WOMAC pain over time. The black line with a circle symbol shows
the group that did not have TKR. The green line with the square symbol shows the
group that had TKR prior to month 72. The navy line with the diamond symbol shows
the group that had TKR prior to month 60. The aqua line with the octagon symbol
shows the group that had TKR prior to month 48. The maroon line with the triangle
symbol shows the group that had TKR prior to month 36. The green line with the
triangle symbol shows the group that had TKR prior to month 24. The pink square
symbol shows the group that had TKR prior to month 12.The relationship between functional decline and chronic rather
than episodic pain has been previously explored in the context of
other chronic pain conditions, particularly in literature evaluating
chronic pain and psychological factors such as pain-related fear30e
33. The model describes how a personwho feels anxiety in response
to pain learns to avoid pain-causing behaviors, leading to the
avoidance of physical activity and the subsequent worsening of the
underlying disease through the disuse and atrophying of muscles.
While this model has been frequently discussed in the context of
chronic lower back pain30,32,34, recent studies have provided
insight into the relationship between pain-related fear, disability,
and knee OA33,35,36. The model reminds us of a basic underlying
challenge in longitudinal pain reporting where subjects may
inadvertently mask pain progression through the modiﬁcation of
the activities they perform in their daily lives or through the con-
sumption of gradually increasing doses of medications over time.
What may appear as a stable pattern of pain may actually reﬂect
increasing pain-related activity limitation and greater reliance
upon analgesics in order to maintain a bearable level of pain.
Seventeen percent of the cohort dropped out of the study while
11% underwent TKR over the course of follow-up. The group-based
trajectory model assumes that missing data are missing at random.
Conditional on the observed outcomes and covariates, missingness
does not depend on unobserved outcomes; in otherwords, attrition
and trajectory group assignment are independent37. The basic tra-
jectory model does not accommodate data that are missing not at
random, meaning the missing data mechanism depends on the
unobserved outcome. In this study, missing not at random would
imply that participants’ decisions to drop out or undergo TKR de-
pends on their unobserved pain, even after taking into account the
longitudinal pain information and covariates observed until the
time of dropout. While we attempted to explore the association
between TKR and trajectory by including TKR as a risk factor in our
model, further work is needed to explore the impact of missing not
at random on pain trajectories. Naturally, TKR is more likely to
occur among those in trajectories characterized by greater pain
levels.
This study has several important limitations. While group-based
trajectory modeling is an established method for analyzing longi-
tudinal data, decisions regarding the number and shape of
Fig. 3. Group-based trajectories by baseline KL group. Each of the three plots displays a different baseline KL group. For each graph, WOMAC pain is along the Y-axis and follow-up
month is along the X-axis. Each line represents one distinct trajectory.
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trajectories, there was variation in pain in each trajectory. These
trajectories do not imply that no individuals worsen or improve
over the course of follow-up; rather, we found no pattern of
improvement or worsening on average within the trajectory-
speciﬁc cohorts. The group-based trajectory method, using SAS
PROC TRAJ, assumes that any individual deviation from the group-
speciﬁc trajectory is due to random error, that is, there is no
subject-speciﬁc random effect. We may wish to investigate
methods that allow individual subjects to vary around group-
speciﬁc trajectories. Secondly, the OAI cohort has been shown to
have a higher self-reported health status compared to a nationally
representative survey of US persons with OA38. The OAI exclusion
criteria, including severe joint space narrowing in both knees
(Osteoarthritis Research Society International (OARSI) joint space
narrowing grade 3 or bone-on-bone), inability to undergo MRI due
to size limits (285 pounds formen and 250 pounds for women), and
comorbid conditions that could interfere with participation, may
have created a relatively healthy OA cohort. This may help to
explain our ﬁnding that older age was associated with being in a
less severe pain trajectory; perhaps older patients in more severe
pain were excluded due to more severe radiographic disease or
other comorbid conditions. Further, the younger subjects are likely
more physical active and therefore more likely to experience use-
related pain. Our results may not be generalizable to the entire
population of persons with OA. In fact, our OAI cohort had less
severe OA symptoms at baseline than two previous studies inves-
tigating symptom trajectories in OA cohorts28,29. Thirdly, as thiswas an observational study, subjects were allowed to continuewith
their usual treatment for OA symptoms, including pain medica-
tions, injections, and physical therapy.
Our study identiﬁed ﬁve distinct pain trajectories in persons
with knee OA: no pain, mild pain, low moderate pain, high mod-
erate pain, and severe pain. None of the trajectories demonstrated
marked improvement or worsening over time, with the exception
of a slight improvement after baseline for all trajectories. Further
work is needed to validate these ﬁndings in an independent cohort.
These ﬁndings suggest that some people may experience OA as a
chronic rather than progressive disease.
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